Israeli ultrasound software co DiACardio has raised $1.95 million in a post-seed financing round led by China’s Shengjing Group. Other investors in the round include CE Ventures and AltaIR as well as existing backers Agate-Mac Fund and Capital Point Ltd.
Based in Beersheva, DiACardio offers software that automates the process of evaluating ultrasounds of the heart, also known as echocardiograms. Based on a new image processing method the company invented, unique and innovative algorithms evaluate the function of the heart fast, accurately and automatically. The software is FDA and CE approved and initial sales have been successfully obtained.
This investment will enable the company to expand its automated toolbox to other areas of the heart that need automation and expand their business in the US, Europe and the emerging markets.
DiACardio was founded in 2010 by chairman Arnon Toussia-Cohen, CEO Hila Goldman-Aslan, inventor and R&D director Michal Yaacobi, inventor Noah Liel-Cohen M.D., and inventor Prof. Hugo Guterman.
Published by Globes [online], Israel business news - www.globes-online.com - on March 20, 2016
© Copyright of Globes Publisher Itonut (1983) Ltd. 2016